Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
accident, ActoGenix, adaptor, Alder, analgesia, anticancer, ascending, autoimmune, Avaxia, BARDA, barrier, biliary, BioAlliance, bomb, Brett, British, broad, cancelled, Caphosol, Chemical, chemo, cliff, Clin, CLIPPER, colloquially, combating, complication, counted, crypt, crystal, Daewoong, debilitating, demineralization, deter, detonation, disaster, Distinguished, dollar, dysregulated, effector, Episil, explosion, factor, Finlay, forfeited, frontline, fullest, GelClair, glucose, greatly, Hancock, healing, histocompatibility, HPA, IDR, Immunol, incessant, ingested, innate, Innaxon, intensifying, interstitial, intolerance, intracellular, invited, IP, joint, keen, link, linked, lymphoproliferative, mechanism, mediated, merged, mucosal, MuGard, myopathy, narcotic, neck, neuropsychiatric, NIAD, notably, nuclear, nutrition, OrbeShield, OTCQB, palifermin, parenteral, pharmacokinetic, poised, PolyMedix, portfolio, problem, professional, profound, prolonged, PTC, reacquiring, recurrent, refractory, renegotiated, renegotiation, rescued, resolution, RFI, RNAi, routinely, RVEc, rvec™, RXi, SA, scleroderma, sight, signal, simultaneously, SINAF, spouse, strong, tender, transduction, trauma, twelve, UBC, VeloThrax, velothrax™, widespread
Removed:
absorption, acceptance, accredited, accrual, adaptable, advantage, advent, aggressive, agonist, agreeable, Amper, Annex, anorexia, Ansan, approvable, arm, attacked, attainment, Australia, averaged, avoid, BAM, Bank, banking, billion, bioavailability, biotherapeutic, BioWa, blind, botulinum, breast, carcinoma, central, chemistry, clarity, clinic, CLIPPERTM, closely, collectible, collection, commenced, comparison, Conference, configuration, contact, cord, curative, currency, CVL, decade, decline, dependant, deposit, depot, destroy, deteriorating, dimension, dispersed, dispersion, Eligard, Emory, enhanced, enhancement, enrolled, enrolling, enrollment, enzyme, establishment, evenly, exfoliation, fatal, fewer, fifty, finalize, founder, founding, genetic, gonadotropin, Goodwill, grown, gut, GVL, harvested, HCT, hedge, hired, historically, hormone, hundred, immunodeficiency, implant, implanted, inborn, incorporate, inflation, inhibit, inhibition, interfere, Junior, layer, left, lengthy, lethality, leukemia, leuprolide, likelihood, liver, LPM, Lupron, malignant, managing, mandate, Martin, Master, matched, Mattia, meaningful, melanoma, men, metastatic, micelle, mild, moderate, myeloablative, nonclinical, Numoda, offering, opportunistic, orbec®, ovarian, Paramount, partly, Paul, peptide, percent, permeable, persist, platform, Politziner, polymer, poor, poorly, powered, procedure, promising, promote, prospect, protocol, Psychology, quickly, randomization, reached, relapse, renal, requested, reviewing, satiety, satisfactory, Schnittker, security, serving, sickle, significance, soluble, solution, spot, stated, statistical, structurally, sublease, thermodynamically, thought, trader, transplanted, treasury, understand, underway, unpaid, untreated, venture, version, water, wife
Filing tables
Filing exhibits
SNGX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Soligenix, Inc. and subsidiaries on Form S-3 (Nos. 333-162375 and 333-167792) and Form S-8 (Nos, 333-157322, 333-149239, 333-162375, and 333-167792) of our report dated February 25, 2013, on our audits of the consolidated financial statements as of December 31, 2012 and 2011 and for each of the years in the two-year period ended December 31, 2012, which report is included in this Annual Report on Form 10-K.
/s/ EisnerAmper LLP
Jenkintown, Pennsylvania
February 25, 2013